Hartgens F, Van Marken Lichtenbelt W D, Ebbing S, Vollaard N, Rietjens G, Kuipers H
The Netherlands' Center for Doping Affairs, Capelle aan den IJssel, NLD.
Phys Sportsmed. 2001 Jan;29(1):49-65. doi: 10.3810/psm.2001.01.316.
Some strength athletes use androgenic-anabolic steroids (AAS) to improve body dimensions, though the drugs' long- and short-term effects have not been definitively established.
This study sought to investigate the short-and long-term effects of AAS self-administration on body dimensions and total and regional body composition.
This prospective, unblinded study involved 35 experienced male strength athletes: 19 AAS users (drugs were self-administered) and 16 nonuser controls engaged in their usual training regimens. At baseline, 8 weeks, and 6 weeks after AAS withdrawal (for AAS users) circumferences were measured at 10 sites, and skinfolds measured at 8 sites. To assess differences in AAS regimens, 9 subjects took AAS for 8 weeks (short-AAS) and 10 athletes took AAS for 12 to 16 weeks (long-AAS). Body composition and anthropometry were assessed at baseline, at the end of AAS use, and 6 weeks later. Lean body mass (LBM) was calculated from body weight and percentage fat. Total and regional body composition was measured by dual-energy x-ray absorptiometry.
AAS use increased users' body weight by 4.4 kg and LBM by 4.5 kg, and produced increases in several circumferences. Percentage of fat decreased (17.0% to 16.0%), but fat mass remained unchanged. Changes persisted 6 weeks after drug withdrawal but were not less than those taken at 8 weeks. Bone-free lean mass of all regional body parts increased in subjects taking AAS, but fat mass was unaffected. Short- and long-term AAS users did not differ in any parameter measured at 8 weeks or after drug withdrawal.
In AAS users, 8 weeks of self-administered AAS increased body weight, lean body mass, and limb circumferences, but decreased percentage fat compared with controls. Changes remained 6 weeks after drug withdrawal, though for some measurements only partially. AAS stimulated the bone-free lean mass of all body parts, but it did not affect fat mass. Short-term and long-term AAS administration produced comparable effects.
一些力量型运动员使用雄激素-合成代谢类固醇(AAS)来改善身体维度,尽管这些药物的长期和短期影响尚未明确确定。
本研究旨在调查自行使用AAS对身体维度以及全身和局部身体成分的短期和长期影响。
这项前瞻性、非盲法研究涉及35名经验丰富的男性力量型运动员:19名AAS使用者(自行用药)和16名非使用者对照组,他们按照常规训练方案进行训练。在基线、8周时以及AAS使用者停药6周后,测量10个部位的周长和8个部位的皮褶厚度。为评估AAS使用方案的差异,9名受试者使用AAS 8周(短期AAS组),10名运动员使用AAS 12至16周(长期AAS组)。在基线、AAS使用结束时以及6周后评估身体成分和人体测量学指标。瘦体重(LBM)由体重和脂肪百分比计算得出。通过双能X线吸收法测量全身和局部身体成分。
使用AAS使使用者体重增加4.4千克,LBM增加4.5千克,并使多个周长增加。脂肪百分比下降(从17.0%降至16.0%),但脂肪量保持不变。停药6周后这些变化仍然存在,但并不小于8周时的变化。使用AAS的受试者所有局部身体部位的去脂瘦体重均增加,但脂肪量未受影响。短期和长期AAS使用者在8周时或停药后所测量的任何参数上均无差异。
在AAS使用者中,自行使用AAS 8周可增加体重、瘦体重和肢体周长,但与对照组相比脂肪百分比下降。停药6周后变化仍然存在,不过某些测量指标只是部分保持变化。AAS刺激了所有身体部位的去脂瘦体重,但未影响脂肪量。短期和长期使用AAS产生了类似的效果。